Kendall video at EASD today

[Clement]

www.easd.org/virtualmeeting/home.html#!resources/total-and-severe-hypoglycaemia-is-reduced-with-use-of-inhaled-technosphere-insulin-ti-relative-to-insulin-aspart-in-type-1-diabetes-af7a875e-36e3-4dce-acb0-86149fb1bbab

slides and audio

[tw12]

He sounds great. Just the right pacing and enunciation for that multi-cultural audience. Here's to European traction for Afrezza!

[MnkdWASmyRtrmntPlan]

Thanks for posting that link, Clement. I agree with you tw, Dr. Kendal gave a great presentation.

[porkini]

Corrected link:

www.easd.org/virtualmeeting/home.html#!resources/total-and-severe-hypoglycaemia-is-reduced-with-use-of-inhaled-technosphere-insulin-ti-relative-to-insulin-aspart-in-type-1-diabetes-af7a875e-36e3-4dce-acb0-86149fb1bbab

[kc]

dead link....

[porkini]

Oct 2, 2018 14:32:09 GMT -5 kc said:

dead link....

I believe mine still works, did you try it? mnkd.proboards.com/post/159446

[mytakeonit]

Hit that "view sessions outline" below the screen ... then, hit the David Kendall link ... it should work. It did for me.

[porkini]

Oct 2, 2018 14:43:38 GMT -5 porkini said:

Oct 2, 2018 14:32:09 GMT -5 kc said:

dead link....

I believe mine still works, did you try it? mnkd.proboards.com/post/159446

Dead now.

[Clement]

Hey, it was good while it lasted! I'm glad some people other than myself got to see it. Kendall did a god job.

[mnholdem]

I’m eager to hear his lung safety presentation next.

[Deleted]

Didn't know where to put this but link from DiaTribe on Day 1 of ESAD.

See paragraph in bold titled "Time-in-range, hypoglycemia predicts complications independent of A1C. Side note: protesters in front of Lilly making their displeasure known for how much Lilly has raised insulin prices. Given Afrezza's superior time in range and reduced incidences of hypoglycemia, Afrezza, because it will reduce long term health complications is vastly underpriced. In a fee for outcomes world, performance matters.


diatribe.org/easd-day-1-highlights-expert-commentary-diabetes-therapy-and-technology-developments?utm_source=ADA+2018+Daily+Updates&utm_campaign=0d36416bac-EMAIL_CAMPAIGN_2018_06_23_03_08_COPY_01&utm_medium=email&utm_term=0_4fb3881c26-0d36416bac-152999267#tir

[sayhey24]

No mention of Dr. Kednall and him showing significant reduction in hypos. That I would have thought would have been the big news of the day. Someone should contact the DiaTribe authors.

However we have Anne Peters saying that the heart-health benefit is one reason many of her type 1 patients want to take an SGLT-2, even though it has not been approved for people with type 1. She ought be being telling them to use afrezza which will provide superior time in range and will "Stop the Spike". That spike is like a dagger to the heart. Forget the sglt-2, save some toes and nuts and prescribe the afrezza.

Maybe Dr. Kendall can have a talk with her especially since she is on his Advisory Board.

[Deleted]

Oct 2, 2018 18:57:40 GMT -5 sayhey24 said:

No mention of Dr. Kednall and him showing significant reduction in hypos. That I would have thought would have been the big news of the day. Someone should contact the DiaTribe authors.

However we have Anne Peters saying that the heart-health benefit is one reason many of her type 1 patients want to take an SGLT-2, even though it has not been approved for people with type 1. She ought be being telling them to use afrezza which will provide superior time in range and will "Stop the Spike". That spike is like a dagger to the heart. Forget the sglt-2, save some toes and nuts and prescribe the afrezza.

Maybe Dr. Kendall can have a talk with her especially since she is on his Advisory Board.

SGLT-2s have some potentially serious side effects, no?  I thought FDA was taking another look at the entire class.  Vioxx redux?

[sayhey24]

The SGLT-2 are a disaster. Here is the latest warning, the loss of nuts - www.medpagetoday.com/endocrinology/generalendocrinology/74879

The amputations of toes and feet are a total disgrace.

[liane]

Let's stay on topic please.